Publications

1. A paradigm shift in perception, learning and action - summary of the second advice of the Committee Innovation Health Care Professions & Education

   Summary of the second report of The Committee Innovation Health Care Professions & Education. This report is a summary of ...

   Report | 23-03-2017

2. Daclizumab (Zinbryta®) for the treatment of relapsing (recidive) forms of multiple sclerosis (RMS)

   The National Health Care Institute carried out a marginal assessment of the medicine daclizumab (Zinbryta ® ), whereby they came ...

   Report | 15-12-2016

3. Palbociclib (Ibrance®) for the treatment of metastatic breast cancer

   The National Health Care Institute carried out an assessment of the medicine palbociclib (Ibrance®), whereby they came to the ...

   Report | 15-12-2016

4. Netupitant - palonosetron (Akynzo®) for the prevention of acute nausea and vomiting associated with highly emetogenic cancer chemotherapy

   The National Health Care Institute has assessed the medicine netupitant/palonosetron (Akynzeo®), whereby they came to the ...

   Report | 31-10-2016

5. Zinnige Zorg room for improvement report - Appropriate use of pharmaceutical products for patients with castration-refractory prostate cancer (CRPC)

   Within the framework of the Zinnige Zorg Programme, Zorginstituut Nederland systematically assesses the Dutch minimal and ...

   Report | 29-07-2016

6. Zinnige Zorg room for improvement report - Appropriate post-treatment surveillance of women treated for breast cancer

   Within the framework of the Zinnige Zorg Programme, the National Health Care Institute systematically assesses the Dutch minimal ...

   Report | 25-07-2016

7. Fingolimod (Gilenya®)

   The National Health Care Institute has advised on amending the conditional inclusion of the medicine fingolimod (Gilenya®) in the ...

   Report | 08-07-2016

8. Future scenarios about drug development and drug pricing

   This report is the result of a consultative and deliberative process — initiated by the Belgian Healthcare Knowledge Centre (KCE) ...

   Report | 28-06-2016

9. Tranylcypromine (Tracydal®) in patients with a severe multi-resistant depressive disorder

   The National Health Care Institute carried out a budget impact analysis for the medicine tranylcypromine (Tracydal®). They ...

   Report | 15-06-2016

10. Tolperison (Tolpermyo®)

    The National Health Care Institute has drawn up a pharmacotherapeutic report for the medicine tolperison (Tolpermyo®), whereby it ...

    Report | 25-05-2016